Home Cart 0 Sign in  

[ CAS No. 573-97-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 573-97-7
Chemical Structure| 573-97-7
Structure of 573-97-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 573-97-7 ]

Related Doc. of [ 573-97-7 ]

Alternatived Products of [ 573-97-7 ]

Product Details of [ 573-97-7 ]

CAS No. :573-97-7 MDL No. :MFCD00003869
Formula : C10H7BrO Boiling Point : -
Linear Structure Formula :- InChI Key :FQJZPYXGPYJJIH-UHFFFAOYSA-N
M.W : 223.07 Pubchem ID :11316
Synonyms :

Calculated chemistry of [ 573-97-7 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 53.67
TPSA : 20.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.5 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.22
Log Po/w (XLOGP3) : 3.05
Log Po/w (WLOGP) : 3.31
Log Po/w (MLOGP) : 3.24
Log Po/w (SILICOS-IT) : 3.16
Consensus Log Po/w : 3.0

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.76
Solubility : 0.0387 mg/ml ; 0.000173 mol/l
Class : Soluble
Log S (Ali) : -3.14
Solubility : 0.161 mg/ml ; 0.000723 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.36
Solubility : 0.0098 mg/ml ; 0.000044 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.18

Safety of [ 573-97-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 573-97-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 573-97-7 ]
  • Downstream synthetic route of [ 573-97-7 ]

[ 573-97-7 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 573-97-7 ]
  • [ 74-88-4 ]
  • [ 3401-47-6 ]
YieldReaction ConditionsOperation in experiment
83% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 12 h; Inert atmosphere 7.0 g (345.2 mmol) of Intermediate M-1 and 95.4 g (690.4 mmol) of potassium carbonate were added to 1000 mL of N, N-dimethylformamide in a 2000 mL flask, and then 32.2 ml of methyl iodide (MeI) (517.7 mmol) was slowly added dropwise.Thereafter, the mixture was stirred at room temperature for 12 hours under a stream of nitrogen.The resulting mixture was added to 3000 mL of distilled water and the crystallized solid was filtered to obtain Intermediate M-2 (101.1 g, 83percent yield).
69%
Stage #1: With potassium hydroxide In dimethyl sulfoxide for 0.166667 h; Inert atmosphere
Stage #2: at 20 - 50℃; for 13 h; Inert atmosphere; Cooling
In a 500 mL round three-necked flask, 2-bromonaphthalen-2-ol (30.0 g, 134.5 mmol)Potassium hydroxide (KOH) (11.3 g, 201.7 mmol)And 300 mL of DMSO,After stirring for 10 minutes under a nitrogen atmosphere,After allowing the reaction to cool in an ice-water container, iodomethane (28.6 g, 201.7 mmol) is slowly added dropwise. When iodomethane injection is completed,After stirring at room temperature for 12 hours in a nitrogen atmosphere,After stirring at 50 ° C. for 1 hour,Lower the temperature to ambient temperature. After mixing with 500 mL of water,Extract with diethyl ether. After washing the organic mixture three times with distilled water,After removing moisture with anhydrous magnesium sulfate (MgSO 4)The solvent was removed by a rotary evaporator,It was purified with normal hexane using a silica gel chromatography tube,22.0 g (yield 69.0percent) of 1-bromo-2-methoxynaphthalene as a white solid content was obtained.
Reference: [1] Patent: KR2016/17530, 2016, A, . Location in patent: Paragraph 0238; 0241; 0245; 0246
[2] Journal of Medicinal Chemistry, 1998, vol. 41, # 24, p. 4800 - 4818
[3] Journal of Organic Chemistry, 2000, vol. 65, # 5, p. 1511 - 1515
[4] Patent: JP5656843, 2015, B2, . Location in patent: Paragraph 0092; 0093
[5] Journal of the Chemical Society, 1900, vol. 77, p. 37
[6] Tetrahedron Letters, 1996, vol. 37, # 51, p. 9245 - 9248
[7] Patent: WO2005/16886, 2005, A1, . Location in patent: Page/Page column 39
  • 2
  • [ 573-97-7 ]
  • [ 77-78-1 ]
  • [ 3401-47-6 ]
Reference: [1] Tetrahedron Asymmetry, 2002, vol. 13, # 6, p. 659 - 665
[2] Phosphorus, Sulfur and Silicon and the Related Elements, 2005, vol. 180, # 7, p. 1701 - 1712
[3] Journal fuer Praktische Chemie (Leipzig), 1921, vol. <2> 103, p. 367
[4] Journal of the Chemical Society [Section] B: Physical Organic, 1968, p. 1112 - 1123
  • 3
  • [ 573-97-7 ]
  • [ 16239-18-2 ]
Reference: [1] RSC Advances, 2018, vol. 8, # 32, p. 17806 - 17812
[2] Journal fuer Praktische Chemie (Leipzig), 1921, vol. <2> 103, p. 367
[3] Justus Liebigs Annalen der Chemie, 1924, vol. 439, p. 237
  • 4
  • [ 7726-95-6 ]
  • [ 64-19-7 ]
  • [ 135-19-3 ]
  • [ 573-97-7 ]
  • [ 16239-18-2 ]
Reference: [1] Journal of the Indian Chemical Society, 1933, vol. 10, p. 595,597
  • 5
  • [ 573-97-7 ]
  • [ 71-36-3 ]
  • [ 10484-56-7 ]
Reference: [1] Green Chemistry, 2011, vol. 13, # 9, p. 2482 - 2488
  • 6
  • [ 573-97-7 ]
  • [ 104116-17-8 ]
Reference: [1] Tetrahedron Asymmetry, 2002, vol. 13, # 6, p. 659 - 665
  • 7
  • [ 573-97-7 ]
  • [ 219834-96-5 ]
Reference: [1] Journal of Organic Chemistry, 1999, vol. 64, # 26, p. 9430 - 9443
Same Skeleton Products
Historical Records